Glycobiology Advance Access published online on January 19, 2007
Glycobiology, doi:10.1093/glycob/cwm004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rho-glucosylating Clostridium difficile toxins A and B: New insights into structure and function
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie der Albert-Ludwigs-Universität Freiburg, Germany
Correspondence address: Dr. Klaus Aktories, Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Otto-Krayer-Haus, Albertstrasse 25, D-79104 Freiburg, Germany, Phone: +49-761-2035301; Fax: +49-761-2035311; E-mail: Klaus.Aktories{at}pharmakol.uni-freiburg.de
Received on December 8, 2006; revised on January 9, 2007; accepted on January 9, 2007
Clostridium difficile causes pseudomembranous colitis and is responsible for many cases of nosocomial antibiotic-associated diarrhea (AAD). Major virulence factors of Clostridium difficile are the glucosylating exotoxins A and B. Both toxins enter target cells in a pH- dependent manner from endosomes by forming pores. They translocate the N-terminal catalytic domains into the cytosol of host cells and inactivate Rho GTPases by glucosylation. The crystal structure of the catalytic domain of toxin B was solved in a complex with UDP, glucose and manganese ion, exhibiting a folding of type A family glycosyltransferases. Crystallization of fragments of the C-terminus of toxin A, which is characterized by polypeptide repeats, revealed a solenoid-like structure often found in bacterial cell surface proteins. These studies, which provide new insights into structure, up-take and function of the family of clostridial glucosylating toxins, are reviewed.
Key words:
Bacterial protein toxins
/
clostridial glucosylating toxins
/
glycosyltransferases
/
crystal structure
/
protein toxin up-take
/
Rho proteins
/
UDP-glucose
/
Clostridium novyi
-toxin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Goto, F. Otsuka, M. Yamashita, J. Suzuki, H. Otani, H. Takahashi, T. Miyoshi, Y. Mimura, T. Ogura, and H. Makino Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E904 - E916. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Entschladen, J. A. Lindquist, E. Serfling, G. Thiel, A. Kieser, K. Giehl, C. Ehrhardt, S. M. Feller, O. Ullrich, F. Schaper, et al. Signal Transduction--Receptors, Mediators, and Genes Sci. Signal., March 24, 2009; 2(63): mr3 - mr3. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Barr, A. G. Ostermeyer-Fay, R. A. Matundan, and D. A. Brown Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells J. Cell Sci., October 1, 2008; 121(19): 3155 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dingle, S. Wee, G. L Mulvey, A. Greco, E. N Kitova, J. Sun, S. Lin, J. S Klassen, M. M Palcic, K. K S Ng, et al. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile Glycobiology, September 1, 2008; 18(9): 698 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Giesemann, M. Egerer, T. Jank, and K. Aktories Processing of Clostridium difficile toxins J. Med. Microbiol., June 1, 2008; 57(6): 690 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Egerer, T. Giesemann, T. Jank, K. J. F. Satchell, and K. Aktories Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity J. Biol. Chem., August 31, 2007; 282(35): 25314 - 25321. [Abstract] [Full Text] [PDF] |
||||





